SCHEMBL22747032

SCHEMBL22747032

c1ccc(-n2c3ccccc3c3cc(-c4ccc(-n5c6ccc(-c7nc8ccccc8o7)cc6c6cc(-c7nc8ccccc8o7)ccc65)cc4)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.46
▸ KDM4E B2RXH2 9/20 0.46
▸ HPGD P15428 8/20 0.46
▸ SMN1; SMN2 Q16637 8/20 0.46
▸ RAB9A P51151 7/20 0.46
▸ ALDH1A1 P00352 7/20 0.46
▸ HSD17B10 Q99714 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ USP2 O75604 2/20 0.46
▸ HCRTR1 O43613 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ TP53 P04637 4/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27282344 0.98 NPC1 (0.46) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL22747038 0.97 NPC1 (0.44) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL10065313 0.96 NPC1 (0.48) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL10065323 0.96 NPC1 (0.48) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL308477 0.96 NPC1 (0.48) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL10065318 0.96 NPC1 (0.47) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL23097242 0.96 KDM4E (0.49) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL22747045 0.96 KDM4E (0.49) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL23097254 0.96 KDM4E (0.49) NPC1KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL10065298 0.96 KDM4E (0.49) NPC1KDM4EHPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377492-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME P&H TECH CO., LTD 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377492-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME OCIAD1, OCIAD2, POU2F1 NPC1 622/4885KDM4E 1834/4885HPGD 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback